NIH Post-Award Rebudgeting: What You Can Move and What Needs Prior Approval
Your grant is awarded, the project starts, and six months in the budget reality looks different from what you proposed. Equipment costs more than expected. A key postdoc leaves. A collaborator wants a formal subaward instead of a consulting arrangement. NIH has clear rules about what you can adjust on your own and what requires a formal request — and most PIs don't know the full boundary until they've already crossed it.
Table of Contents
Why Rebudgeting Questions Come Up So Often
Grants are budgeted 12 to 18 months before the work actually starts. By the time the award arrives, the personnel landscape, equipment prices, and scientific direction have all had time to shift. A proposed postdoc may have taken another position. The core facility rate you quoted in the budget justification got updated. A collaborator now wants a subaward rather than a consultant arrangement. These are normal adjustments, not failures of planning. NIH expects them.
The question is not whether to adjust your budget — it's how. Make a change that falls within NIH's standard flexibility and you document it in your RPPR and move on. Make a change that crosses a prior approval threshold without asking first, and you risk an audit finding, a cost disallowance, or a compliance issue that follows the grant into its competitive renewal. Grants management specialists at your institution know these rules cold. Many PIs do not, which is where problems start.
One thing worth flagging upfront: the rules described here come from the NIH Grants Policy Statement (NIHGPS), which governs most NIH research grants under standard terms. If your award includes special terms and conditions — as many U-mechanism cooperative agreements do — the Notice of Award itself takes precedence. Always read your NoA before assuming the standard flexibility applies.
The 25% Flexibility Rule: What It Actually Says
The NIH Grants Policy Statement gives grantees one broad default flexibility: you can rebudget between direct cost categories up to 25% of the total award amount in a given budget period without requesting prior NIH approval, as long as the rebudgeting does not involve a change in scope. This is the rule most PIs invoke when they need to shift personnel costs to supplies, or move money from travel to equipment midway through a year.
The 25% figure refers to the NIH-awarded direct cost total — not including F&A (indirect costs). If your direct cost award for a budget period is $200,000, you can move up to $50,000 between categories on your own authority. That sounds like substantial room. In practice, moves of that magnitude almost always raise scope concerns, which brings in a separate constraint.
The scope constraint is what catches people off guard. "Change in scope" is not a precisely defined phrase in federal regulations, but NIH interprets it to mean a significant shift in the aims, methods, or direction of the project as approved. If you proposed to study Protein A and want to pivot to Protein B, that's a change in scope regardless of whether you're moving money. If you proposed to use a mouse model and want to shift to a rat model, whether that constitutes a scope change depends on how central the model choice was to the approved aims. When in doubt, call your grants management specialist. They'd rather field a five-minute question than untangle a compliance issue at your competitive renewal submission.
One more nuance: the 25% flexibility applies to moves between budget categories within a budget period. It does not let you increase the total award amount, and it cannot be used to add budget items that were explicitly excluded from the approved budget — for instance, foreign travel, if your award prohibited it. Working within your award ceiling is non-negotiable; the 25% rule only addresses where within that ceiling you can move funds.
Budget Categories and How NIH Classifies Them
NIH applications use a standard set of direct cost categories that appear in the SF 424 (R&R) budget forms: personnel (salary and fringe), consultant costs, equipment, supplies, travel, patient care costs where applicable, and other direct costs. Each category is tracked separately in your financial system and reported separately in the RPPR. Within the 25% flexibility, you can generally move between these categories freely — subject to scope. A few categories carry their own rules that operate independently of the 25% threshold.
Equipment above your institution's capitalization threshold
Under current NIH policy, equipment costing above your institution's capitalization threshold (which must be at least the federal floor — confirm with your grants office) requires prior approval if it was not included in the approved budget. A microscope or sequencer that wasn't in your original budget needs a prior approval request even if the dollar amount falls under 25% of your direct costs. The category-specific rule overrides the general flexibility.
Foreign travel and foreign components
If your award does not already include approved foreign travel, adding it requires prior approval. Adding a foreign component — any significant activity conducted outside the United States, regardless of whether a subaward is involved — also always requires prior approval. This catches people who invite an international collaborator to conduct work abroad and assume the standard flexibility covers it. It does not.
Adding a new subaward to an unapproved organization
Adding a subaward to an organization that was not included in the approved budget requires prior approval, even when the dollar amount is small. This includes moving work to a collaborator's institution under a formal consortium agreement. The 25% flexibility does not cover the creation of new subaward relationships — only rebalancing among categories that were already present.
What Always Requires Prior Approval
Beyond the 25% threshold and the category-specific rules above, NIH's standard terms list several actions that require prior approval regardless of dollar amount. These are worth knowing by heart because they come up in nearly every multi-year grant at least once.
Change of Principal Investigator or designated key personnel
Any change in PI, co-PI, or personnel listed as "key" in your application requires prior NIH approval. This includes the departure of key personnel even when you're not replacing them immediately. Notify NIH and your grants management specialist as soon as you know about the change — do not wait until the next RPPR filing window.
Significant expansion of human subjects or vertebrate animal work
Expanding the use of human subjects or vertebrate animals beyond what was approved — including new species, new populations, or new protocols — requires NIH prior approval in addition to any IRB or IACUC amendment your institution requires. The two processes run in parallel; NIH approval does not substitute for your local review board.
Rebudgeting that reflects a change in scope
If the rebudgeting reflects or would enable a significant shift in scientific direction, methods, or aims, prior approval is required even if the dollar movement is under 25%. NIH program staff sometimes compare your RPPR narrative to your original Research Strategy — the two need to stay compatible. If you're moving money to fund work that wasn't described in the funded application, that's the conversation to have with your program officer before it shows up in an RPPR.
Carryover of unobligated balance (most awards)
Unless your Notice of Award explicitly grants automatic carryover authority, spending unobligated funds from one budget period in a subsequent period requires prior approval. Many RPG research project grant awards do include automatic carryover — check your NoA carefully — but do not assume it. This matters most when a budget period ends with significant unspent funds, which NIH program staff will notice.
How to Submit a Prior Approval Request
Prior approval requests do not go directly to NIH from the PI — they go through your institution's sponsored research or grants management office. Your institution's authorized institutional representative (the AOR) submits on your behalf, typically by email to the NIH Grants Management Specialist named in your Notice of Award. Do not reach out to your NIH Program Officer for prior approvals; program officers handle the science and strategy, not compliance and budget administration.
A clear prior approval request includes: the grant award number and budget period affected, the specific action being requested (rebudgeting, equipment purchase, subaward addition, key personnel change, etc.), a brief scientific justification of two to four sentences, and — for budget-related requests — a revised budget table showing the proposed changes side by side with the current approved figures. NIH typically responds within two to four weeks, though turnaround varies by institute and time of year. Submit with enough lead time that you are not waiting for an answer when you need to issue a purchase order or sign a subaward agreement.
Frame the justification in terms of how the change still supports the originally approved aims. Even when the science has evolved, the request should explain how the proposed budget reflects the best use of resources to achieve the stated goals. Requests that read as "the project changed direction and we need the money there now" tend to prompt follow-up questions or a scope review. The framing should be: the goals are the same, the most efficient path to those goals has shifted, and here is why.
Documenting Rebudgets in Your RPPR
The Research Performance Progress Report is where routine rebudgeting gets documented even when it did not require prior approval. The financial section of the RPPR captures actual expenditures by category and any significant variances from the approved budget. If you moved funds within your 25% authority, note it in the appropriate RPPR section and briefly explain why — a sentence or two is usually sufficient. What you want to avoid is a large unexplained variance that prompts a grants management inquiry mid-year.
The narrative sections of the RPPR are also where NIH program staff read for signs of scope changes. If your budget variances look consistent with a significant shift in scientific direction, program staff may ask questions or flag the award for review even if the numbers were within your flexibility. Keeping the narrative aligned with the approved aims — and being transparent when the direction has evolved — is the cleanest path through this annual exercise. If you think the science has moved materially since the funded application, discuss it with your Program Officer before filing your RPPR, not after. That conversation is free; the compliance problem that results from not having it is not.
Frequently Asked Questions
Can I use the 25% flexibility to pay myself more salary?
Yes, with two constraints. First, your total institutional base salary times your effort level must not exceed the NIH salary cap — check the current Executive Level II figure before budgeting, as it is adjusted annually. Second, you cannot increase your own effort beyond what your institution's effort reporting system can document without corresponding reductions elsewhere in your commitments. Moving money into your salary line does not by itself justify higher effort; the actual work has to be there and documented.
What if I already exceeded the 25% threshold without requesting approval?
Report it to your grants management office immediately. NIH can retroactively authorize the rebudgeting in many cases, especially when there was no change in scope and the funds were clearly used in support of the project goals. Proactive disclosure with a clear justification dramatically improves the outcome compared to having an auditor or program officer find it during a review. Self-reporting is always the better path.
Does the 25% rule apply per-aim or per-budget-period?
Per budget period, on the total NIH-awarded direct costs for that period. There is no per-aim accounting in NIH budgets. Aims are organizational tools for the science; the budget is tracked at the project level. Calculate the 25% against the total direct cost award for the current budget period, not divided across aims or subaims.
My subcontract institution wants to rebudget their portion of the work. Whose rules apply?
The prime grant's NIH terms govern. The subawardee may have latitude within their own institutional policies for smaller administrative moves, but significant rebudgeting at the subcontract level that affects scope or pushes the aggregate move across the 25% threshold for the prime grant still requires NIH prior approval coordinated through the prime grantee institution. Your grants management office and the subcontract institution's sponsored research office need to be talking to each other — not just you and the subcontract PI.
Stay on Top of Your Grant Portfolio
Managing your NIH grant compliance is easier when you can quickly see what is funded, what is due for renewal, and how your area is shifting. Use these tools to keep the bigger picture in view.
Related Reading
Explore more resources to enhance your NIH funding knowledge
NIH No-Cost Extensions: When to Request One and How to Justify It
When a no-cost extension is your best option, how to request it, and how to avoid having it used against you at competitive renewal.
The RPPR: How to Write an Annual Progress Report That Sets Up Your Renewal
What NIH actually looks for in the RPPR, how to frame progress and problems, and how to use the annual report to build your competitive renewal narrative.
NIH Budget Justification: What Reviewers Actually Read and Why It Matters
A guide to writing budget justifications that hold up under review — what to say about personnel, equipment, subawards, and anything the numbers alone do not explain.
When NIH Cuts Your Budget Below the Reviewed Amount
NIH institutes are now routinely cutting awarded budgets below the peer-reviewed level. A practical guide to why it happens and how to respond.
Trust & Transparency
How this content is reviewed before it goes live
NIH Grant Explorer combines public NIH records with editorial interpretation. We publish the review structure, methodology, and correction pathways so readers can judge the value of a guide or chart for themselves.
When a topic turns into an official policy question, we point readers back to NIH rather than pretending an independent site can replace the underlying federal guidance.
Contributors & Review Desks
See how data, strategy, and career-focused pages are reviewed.
Editorial Guidelines
How we source, update, and correct articles and tool explanations.
Data & Methodology
Refresh cadence, public-source coverage, and chart caveats.
Corrections & Contact
Send corrections, feedback, or contributor inquiries.